Actinomycosis: Symptoms, Causes, and Treatment

What Is Actinomycosis?

Actinomycosis is a rare, chronic bacterial infection caused by Actinomyces species — anaerobic, Gram-positive, branching filamentous bacteria that normally colonise the human mouth, digestive tract, and female genital tract.^[1] Actinomyces israelii is the species most often isolated in human infection, and together with A. gerencseriae accounts for roughly 70% of orocervicofacial cases.^[1]

The infection is unusual in three respects, and each one explains why it is so often missed:

• It is endogenous. The bacteria are already present as commensals. Disease begins only when a mucosal barrier is broken.
• It spreads contiguously. Actinomycosis crosses fascial planes and anatomical barriers rather than travelling through lymphatics, producing sinus tracts and fistulae.
• It mimics cancer. At virtually every anatomical site, a cold, firm, slowly enlarging mass raises suspicion of malignancy or tuberculosis long before infection is considered.^[1]

Estimates of incidence in the antibiotic era are in the range of roughly one case per 300,000 people per year, making it a genuinely uncommon diagnosis that most clinicians see rarely.^[2]

Symptoms of Actinomycosis

Symptoms depend on the anatomical site, but the shared pattern is a chronic, indolent, suppurative process rather than an acute febrile illness.

Cervicofacial ("lumpy jaw") — the most common form. A slowly progressive, often painless indurated mass around the mandible, typically after a dental focus of infection. Over weeks it evolves into multiple abscesses with draining sinus tracts onto the skin or oral mucosa, sometimes expressing thick yellow exudate containing sulfur granules. Pain and trismus appear later as the muscles of mastication are infiltrated. Regional lymphadenopathy is uncommon, which is one clue that this is not ordinary dental sepsis; bone involvement occurs in around 10% of cases.^[1]

Thoracic. Productive cough, haemoptysis, dyspnoea, chest pain, weight loss, fever, and night sweats — closely resembling tuberculosis or lung cancer. A pulmonary cavity combined with a chest-wall sinus tract is a strong pointer toward actinomycosis.^[1]

Abdominopelvic. Abdominal pain with a palpable mass, most often involving the appendix, caecum, or colon, and sometimes complicated by abdominal-wall fistula. Liver involvement may present as right upper quadrant pain and jaundice.^[1]

Pelvic, in intrauterine device users. A genital or pelvic mass usually without fever, with lower abdominal pain, constipation, or vaginal discharge, typically about two months old at diagnosis. Inflammatory markers are raised and CA-125 may be elevated, which makes the picture difficult to distinguish from ovarian malignancy on presentation.^[1][3]

Central nervous system. Usually brain abscess, with focal weakness, sensory loss, or seizures. CNS actinomycosis is typically polymicrobial.^[1]

What Causes Actinomycosis?

Actinomyces species cause no disease while they remain on the mucosal surface. The infection requires a breach.^[1]

Predisposing factors:

• Dental caries, gingivitis, and periodontal disease
• Dental extraction, root canal treatment, or other oral mucosal trauma
• Abdominal surgery, appendicitis, or perforated diverticulitis
• Foreign bodies — intrauterine devices, dental implants, stents, surgical mesh
• Irradiated or devitalised tissue; bisphosphonate-associated osteonecrosis of the jaw
• Diabetes, alcohol use, malnutrition, immunosuppression

Companion organisms matter. Actinomycosis is characteristically polymicrobial. Co-isolated commensals such as Eikenella corrodens, Aggregatibacter actinomycetemcomitans, Haemophilus species, and fusobacteria appear to lower local oxygen tension and impair host defences, helping Actinomyces establish itself.^[1]

Once in deep tissue, the organisms form dense masses of interlinked branching filaments held in a protein-polysaccharide matrix that resists phagocytosis — the structural basis of both the sulfur granule and the disease's stubborn chronicity.^[1]

Diagnosis

Diagnosis is difficult and frequently delayed. Two principles do most of the work.

Send tissue or pus, not a swab. The appropriate specimens are surgical biopsy tissue or aspirated pus, transported rapidly and/or in anaerobic transport medium and incubated anaerobically. Growth may take 5 days to appear and up to 15-20 days to develop, so plates should be held at least 10 days before being called negative — and bone samples for two weeks.^[1]

A negative culture does not exclude the diagnosis. Cultures remain sterile in more than 50% of cases, because of prior antibiotic therapy, overgrowth by faster-growing co-pathogens, loss of viability in transport, or premature incubation cut-off. Gram staining of pus is usually more sensitive than culture, particularly in patients already treated with antibiotics.^[1]

Histopathology. Sulfur granules — yellow clumps 0.1-1 mm across, containing no sulfur despite the name — appear as basophilic masses with eosinophilic terminal clubs on H&E, and are found in about 75% of cases. Gram staining showing Gram-positive filamentous branching bacteria at the granule periphery is what makes the finding specific, since similar granules occur in nocardiosis and chronic fungal infection.^[1]

Species identification. 16S rRNA gene sequencing is the reference standard, having replaced phenotypic biochemical panels that misidentified Actinomyces at both species and genus level. MALDI-TOF mass spectrometry is reliable at the genus level but less certain at species level.^[1][4]

Full laboratory detail — Gram stain appearance, culture media, and the Nocardia differential — is covered on the Actinomyces israelii organism page.

Actinomycosis vs. Nocardiosis

Sources: actinomycosis^[1][2]; nocardiosis^[5]

Treatment

Drug resistance is not a significant obstacle in actinomycosis: Actinomyces species are highly susceptible to beta-lactams and do not produce beta-lactamases. The challenge is penetration into abscesses and fibrotic tissue, which is why doses are high and courses are long.^[1]

First-line therapy

• Intravenous induction: penicillin G up to 24 million units/day, or high-dose amoxicillin (up to 200 mg/kg/day), for 2-6 weeks
• Oral continuation: penicillin V or amoxicillin for 6-12 months

Alternatives in penicillin allergy: clindamycin, macrolides (erythromycin, clarithromycin, azithromycin), or doxycycline, which has weaker in vitro activity but better bone penetration.^[1]

Agents that do not work: metronidazole and aminoglycosides have no in vitro activity against Actinomyces. Oxacillin, cloxacillin, and cephalexin are also inactive, and fluoroquinolone activity is considered poor.^[1]

Surgery. Drainage of large abscesses, marsupialisation of chronic sinus tracts, excision of recalcitrant fibrotic lesions, and debridement of necrotic bone are often required, alongside dental treatment of the causative focus. In intrauterine-device-associated pelvic disease, removal of the device is central to management.^[1][3]

Duration. The traditional 6-12 month course can likely be shortened where infected tissue has been optimally resected, there is no bone involvement, and the patient responds quickly; satisfactory cure rates have been reported with substantially shorter regimens.^[1]

Prevention

There is no vaccine and no probiotic strategy with evidence against actinomycosis. Prevention is about removing the conditions that let a commensal cross into deep tissue.^[1]

• Dental hygiene and timely dental care, which reduce the odontogenic focus behind most cervicofacial and many thoracic cases. Broader oral-microbiome context is covered in the oral and dental health protocol.
• Reducing heavy alcohol use, a recognised risk factor for pulmonary and cervicofacial disease.
• Replacing intrauterine devices on schedule. Risk of pelvic actinomycosis rises with duration of device use; the actinomycosis literature commonly cites replacement every 5 years. Colonisation is not infection — asymptomatic women with Actinomyces-like organisms on cervical cytology who replace their device on schedule are not treated with antibiotics.^[1][3]

Outlook

With appropriate prolonged antibiotic therapy, and surgery where it is needed, outcomes in actinomycosis are generally good. The main determinants of a poor result are delayed diagnosis, extensive bone involvement, and premature discontinuation of therapy, which is associated with relapse.^[1]

This page is an educational reference, not medical advice. Actinomycosis requires diagnosis and management by a qualified clinician; the doses and durations above summarise published review data and are not a treatment recommendation.